Acorn Biolabs specializes in cryopreserving hair follicle-derived stem cells at -196° Celsius to halt cellular aging, enabling future regenerative treatments. This approach addresses the decline in stem cell efficacy and diversity that occurs with age, providing a long-term resource for personalized therapies in skin rejuvenation, hair regrowth, and injury recovery.
Funding
$10.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

ACCCDFounders
Product
Problem
As individuals age, the regenerative capacity and diversity of their stem cells decline, limiting the potential effectiveness of future cell-based therapies. This age-related degradation reduces the efficacy of treatments for skin rejuvenation, hair regrowth, and injury recovery.
Solution
Acorn Biolabs offers a service to cryopreserve hair follicle-derived stem cells, halting cellular aging and preserving them for future regenerative medicine applications. A trained technician extracts hair follicles, which are then analyzed for viability and cryogenically frozen at -196° Celsius. These preserved cells can be used to produce personalized stem cell-based treatments, rich in exosomes, growth factors, and matrix molecules. This approach provides a long-term resource of younger, more effective cells for personalized therapies as regenerative medicine advances.
Target Audience
Individuals interested in preserving their stem cells for potential future use in regenerative medicine, anti-aging treatments, and personalized therapies.
Features
- Non-invasive collection of hair follicles from the scalp.
- Comprehensive cell viability analysis prior to cryopreservation.
- Cryogenic freezing at -196° Celsius to halt cellular aging.
- Long-term storage of stem cells for future use.
- Potential for personalized stem cell-based topical treatments.
- Hair follicles contain a diversity of valuable tissues and stem cells, including keratinocytes, fibroblasts, and progenitor stem cells.